Highlights in Myelodysplastic Syndromes From the 2020 American Society of Clinical Oncology Annual Meeting and the 25th European Hematology Association Congress: Commentary

被引：0

作者：

Garcia-Manero, Guillermo ^{[1
,2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Translat Res, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Myelodysplast Syndromes, Houston, TX 77030 USA

来源：

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2020年 / 18卷 / 09期

关键词：

AZACITIDINE; VENETOCLAX; INHIBITOR;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：20 / 23

页数：4

共 30 条

[1]

Ades L, 2020, HEMASPHERE, V4, P46

[2]

[Anonymous], 2020, REBL

[3] Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure [J].

Ball, Brian J. ;

Famulare, Christopher A. ;

Stein, Eytan M. ;

Tallman, Martin S. ;

Derkach, Andriy ;

Roshal, Mikhail ;

Gill, Saar, I ;

Manning, Benjamin M. ;

Koprivnikar, Jamie ;

McCloskey, James ;

Testi, Rebecca ;

Prebet, Thomas ;

Al Ali, Najla H. ;

Padron, Eric ;

Sallman, David A. ;

Komrokji, Rami S. ;

Goldberg, Aaron D. .

BLOOD ADVANCES, 2020, 4 (13) :2866-2870

[4]

Borate U, 2020, 25 EUR HEM ASS C JUN

[5]

Cluzeau T, 2020, 25 EUR HEM ASS C JUN

[6] Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia [J].

DiNardo, C. D. ;

Jonas, B. A. ;

Pullarkat, V. ;

Thirman, M. J. ;

Garcia, J. S. ;

Wei, A. H. ;

Konopleva, M. ;

Doehner, H. ;

Letai, A. ;

Fenaux, P. ;

Koller, E. ;

Havelange, V. ;

Leber, B. ;

Esteve, J. ;

Wang, J. ;

Pejsa, V. ;

Hajek, R. ;

Porkka, K. ;

Illes, A. ;

Lavie, D. ;

Lemoli, R. M. ;

Yamamoto, K. ;

Yoon, S. -S. ;

Jang, J. -H. ;

Yeh, S. -P. ;

Turgut, M. ;

Hong, W. -J. ;

Zhou, Y. ;

Potluri, J. ;

Pratz, K. W. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07) :617-629

[7]

Fenaux P, 2020, 25 EUR HEM ASS C JUN

[8] Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes [J].

Fenaux, Pierre ;

Platzbecker, Uwe ;

Mufti, Ghulam J. ;

Garcia-Manero, Guillermo ;

Buckstein, Rena ;

Santini, Valeria ;

Diez-Campelo, Maria ;

Finelli, Carlo ;

Cazzola, Mario ;

Ilhan, Osman ;

Sekeres, Mikkael A. ;

Falantes, Jose F. ;

Arrizabalaga, Beatriz ;

Salvi, Flavia ;

Giai, Valentina ;

Vyas, Paresh ;

Bowen, David ;

Selleslag, Dominik ;

DeZern, Amy E. ;

Jurcic, Joseph G. ;

Germing, Ulrich ;

Goetze, Katharina S. ;

Quesnel, Bruno ;

Beyne-Rauzy, Odile ;

Cluzeau, Thomas ;

Voso, Maria-Teresa ;

Mazure, Dominiek ;

Vellenga, Edo ;

Greenberg, Peter L. ;

Hellstrom-Lindberg, Eva ;

Zeidan, Amer M. ;

Ades, Lionel ;

Verma, Amit ;

Savona, Michael R. ;

Laadem, Abderrahmane ;

Benzohra, Aziz ;

Zhang, Jennie ;

Rampersad, Anita ;

Dunshee, Diana R. ;

Linde, Peter G. ;

Sherman, Matthew L. ;

Komrokji, Rami S. ;

List, Alan F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (02) :140-151

[9] The Medalist Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions [J].

Fenaux, Pierre ;

Platzbecker, Uwe ;

Mufti, Ghulam J. ;

Garcia-Manero, Guillermo ;

Buckstein, Rena ;

Santini, Valeria ;

Diez-Campelo, Maria ;

Finelli, Carlo ;

Cazzola, Mario ;

Ilhan, Osman ;

Sekeres, Mikkael A. ;

Falantes, Jose F. ;

Arrizabalaga, Beatriz ;

Salvi, Flavia ;

Giai, Valentina ;

Vyas, Paresh ;

Bowen, David ;

Selleslag, Dominik ;

DeZern, Amy E. ;

Jurcic, Joseph G. ;

Germing, Ulrich ;

Goetze, Katharina S. ;

Quesnel, Bruno ;

Beyne-Rauzy, Odile ;

Cluzeau, Thomas ;

Voso, Maria Teresa ;

Mazure, Dominiek ;

Vellenga, Edo ;

Greenberg, Peter L. ;

Hellstrom-Lindberg, Eva ;

Zeidan, Amer M. ;

Laadem, Abderrahmane ;

Benzohra, Aziz ;

Zhang, Jennie ;

Rampersad, Anita ;

Linde, Peter G. ;

Sherman, Matthew L. ;

Komrokji, Rami S. ;

List, Alan F. .

BLOOD, 2018, 132

[10]

Garcia-Manero G, 2020, 25 EUR HEM ASS C JUN

← 1 2 3 →